The American Gastroenterological Association (AGA) today released a new clinical practice guideline on the surveillance of Barrett's esophagus, the only known precursor to esophageal cancer ...

Traditionally, Barrett's esophagus was defined as the presence of columnar mucosa extending ≥ 3 cm into the tubular esophagus. This definition has evolved into the presence of any specialized columnar ...

The American Gastroenterological Association (AGA) released a new clinical practice guideline on the surveillance of Barrett's esophagus, the only known precursor to esophageal cancer (adenocarcinoma) ...

The method, if validated in further study, potentially could be used as a reflex test to indicate which patients should have endoscopy for a definitive diagnosis. A description of the work was ...

IN THIS MORNING’S MEDICAL ALERT, APRIL IS ESOPHAGEAL AWARENESS MONTH. AND HERE TO TELL US ABOUT THE DISEASE, WHO IT AFFECTS, AND THE WARNING SIGNS IS PRESIDENT AND CEO OF THE ESOPHAGEAL CANCER ACTION ...

October 30, 2006 (Las Vegas) — A medical approach consisting of 3 agents ("triple therapy") can reverse Barrett's esophagus and the dysplasia that often follows, eliminating the risk for esophageal ...

Researchers set out to compare radiofrequency ablation and endoscopic surveillance in Barrett’s esophagus patients with low-grade dysplasia in a recent study published in the Journal of the American ...

Helicobacter pylori (H. pylori) is a ubiquitous human pathogen that infects up to 50% of the world's population. Its involvement in the etiology of various gastrointestinal disorders, including ...

Please provide your email address to receive an email when new articles are posted on . A capsule-sponge test may help risk-stratify patients with Barrett’s esophagus. Patients classified as low risk ...

Trouble swallowing and chronic cough could signal serious GERD complications. A digestive health expert explores when heartburn becomes a cancer risk concern.

Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a known precursor to esophageal cancer, according to a new study from ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received assay ...